|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Eastern Cooperative Oncology Group National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00002668 |
Purpose
RATIONALE: An outpatient educational and behavioral skills training program may help patients with metastatic breast or prostate cancer live longer and more comfortably.
PURPOSE: This randomized clinical trial studies whether an outpatient educational and behavioral skills training program will improve pain control in patients who have metastatic or recurrent breast or prostate cancer.
| Condition | Intervention |
|
Breast Cancer Pain Prostate Cancer |
Procedure: pain therapy Procedure: psychosocial assessment and care |
| Genetics Home Reference related topics: | breast cancer |
| MedlinePlus related topics: | Breast Cancer Cancer Prostate Cancer |
| Study Type: | Interventional |
| Study Design: | Other, Randomized |
| Official Title: | PATIENT SKILLS FOR CANCER PAIN CONTROL IN PATIENTS WITH METASTATIC BREAST OR PROSTATE CANCER |
| Estimated Enrollment: | 96 |
| Study Start Date: | October 1995 |
OBJECTIVES:
OUTLINE: This is a randomized study. Patients are stratified according to diagnosis (breast vs prostate cancer), initial "pain worst" score (4-6 vs 7 or higher), and participating institution. Patients are randomized to 1 of 2 treatment arms.
Patients on both arms undergo pain and psychological assessments on days 1 and 15.
PROJECTED ACCRUAL: A total of 96 patients (48 per arm) will be accrued for this study.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Hormone receptor status:
PATIENT CHARACTERISTICS:
Age:
Menopausal status:
Performance status:
Hematopoietic:
Hepatic:
Renal:
Other:
No major psychiatric illness, including the following DSM-III-R diagnoses:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Contacts and Locations| United States, Illinois | |||||
| CCOP - Carle Cancer Center | |||||
| Urbana, Illinois, United States, 61801 | |||||
| United States, Iowa | |||||
| CCOP - Cedar Rapids Oncology Project | |||||
| Cedar Rapids, Iowa, United States, 52403-1206 | |||||
| CCOP - Iowa Oncology Research Association | |||||
| Des Moines, Iowa, United States, 50309-1016 | |||||
| Iowa Lutheran Hospital | |||||
| Des Moines, Iowa, United States, 50316-2301 | |||||
| John Stoddard Cancer Center at Iowa Methodist Medical Center | |||||
| Des Moines, Iowa, United States, 50309 | |||||
| Mercy Cancer Center at Mercy Medical Center-Des Moines | |||||
| Des Moines, Iowa, United States, 50314 | |||||
| United States, Louisiana | |||||
| CCOP - Ochsner | |||||
| New Orleans, Louisiana, United States, 70121 | |||||
| United States, Minnesota | |||||
| CCOP - Metro-Minnesota | |||||
| Saint Louis Park, Minnesota, United States, 55416 | |||||
| United States, Nebraska | |||||
| Midlands Cancer Center at Midlands Community Hospital | |||||
| Papillion, Nebraska, United States, 68128-4157 | |||||
| United States, New Jersey | |||||
| CCOP - Northern New Jersey | |||||
| Hackensack, New Jersey, United States, 07601 | |||||
| United States, New Mexico | |||||
| MBCCOP - University of New Mexico HSC | |||||
| Albuquerque, New Mexico, United States, 87131 | |||||
| United States, Pennsylvania | |||||
| CCOP - MainLine Health | |||||
| Wynnewood, Pennsylvania, United States, 19096 | |||||
| Penn State Cancer Institute at Milton S. Hershey Medical Center | |||||
| Hershey, Pennsylvania, United States, 17033-0850 | |||||
| United States, South Dakota | |||||
| CCOP - Sioux Community Cancer Consortium | |||||
| Sioux Falls, South Dakota, United States, 57104 | |||||
| United States, Wisconsin | |||||
| CCOP - St. Vincent Hospital Cancer Center, Green Bay | |||||
| Green Bay, Wisconsin, United States, 54307-3453 | |||||
| Australia, New South Wales | |||||
| Westmead Hospital | |||||
| Westmead, New South Wales, Australia, 2145 | |||||
| Peru | |||||
| Instituto de Enfermedades Neoplasicas | |||||
| Lima, Peru, 34 | |||||
| Puerto Rico | |||||
| San Juan City Hospital | |||||
| San Juan, Puerto Rico, 00936-7344 | |||||
| Eastern Cooperative Oncology Group |
| National Cancer Institute (NCI) |
| Study Chair: | Charles Cleeland, PhD | M.D. Anderson Cancer Center |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000064257, ECOG-3Z93, NCI-P95-0068 |
| First Received: | November 1, 1999 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00002668 |
| Health Authority: | United States: Federal Government |
|
|
|
|